The concerns for induction of anaesthesia in patients undergoing cardiac surgery include hemodynamic stability, attenuation of stress response and maintenance of balance between myocardial oxygen demand and supply. Various Intravenous anaesthetic agents like Thiopentone, Etomidate, Propofol, Midazolam, and Ketamine have been used for anesthetizing patients for cardiac surgeries. However, many authors have expressed concerns regarding induction with thiopentone, midazolam and ketamine. Hence, Propofol and Etomidate are preferred for induction in these patients. However, these two drugs have different characteristics. Etomidate is preferred for patients with poor left ventricular (LV) function as it provides stable cardiovascular profile. But there are concerns about reduction in adrenal suppression and serum cortisol levels. Propofol, on the other hand may cause a reduction in systemic vascular resistance and subsequent hypotension. Thus, this study was conducted to compare induction with these two agents in cardiac surgeries. Methods: Baseline categorical and continuous variables were compared using Fisher's exact test and student's t test respectively. Hemodynamic variables were compared using student's t test for independent samples. The primary outcome (serum cortisol and blood sugar) of the study was compared using Wilcoxon Rank Sum test. The P value less than 0.05 was considered significant. Results: Etomidate provides more stable hemodynamic parameters as compared to Propofol. Propofol causes vasodilation and may result in drop of systematic BP. Etomidate can therefore be safely used for induction in patients with good LV function for CABG/MVR/AVR on CPB without serious cortisol suppression lasting more than twenty-four hours.
INTRODUCTION
The considerations for induction of anesthesia in patients undergoing cardiac surgery include hemodynamic stability, attenuation of the stress responses and maintenance of balance between myocardial oxygen demand and supply. Various intravenous (IV) inducing agents like thiopentone, etomidate, surgeries. [6] [7] [8] [9] [10] The two drugs however have different induction characteristics.
Etomidate, first introduced in the seventies, was withdrawn, because of anaphylactic reactions to Cremaphore EL. There were also concerns about reductions in the serum cortisol levels, [9, 11, 12] which lasts for up to 24 h. However, It has a very stable cardiovascular profile [1, 13, 14] and has been reintroduced in India. Etomidate is recommended for induction in patients with poor left ventricular (LV) function. While, propofol may cause a reduction in systemic vascular resistance (SVR).
Hence, this study was conducted to compare the effect of anesthetic induction with single dose etomidate versus propofol on serum cortisol levels and hemodynamics.
MATERIALS AND METHODS
After obtaining Institutional Ethics Committee approval and written informed consent from the patients, 60 patients (age: 20-60 years, weight: 40-70 kg) of American Society of Anesthesiologists Grade II and III scheduled for elective coronary artery bypass grafting (CABG)/mitral valve replacement (MVR)/aortic valve replacement (AVR) on cardiopulmonary bypass (CPB) were enrolled in this prospective randomized study.
Patients undergoing emergency surgery, having congestive cardiac failure, renal dysfunction (serum creatinine >2 mg/dl), on mechanical ventilation or on long-term steroid therapy, known adrenal or endocrine dysfunction were excluded from the study.
Proper preanesthetic check-up and all relevant investigations were done for all patients.
The patients were randomly divided into two groups of 30 patients each.
Propofol was chosen as other inducing agents like thiopentone and ketamine are not routinely used in MVR and CABG surgeries.
Group I: Injection propofol (P) group (2 mg/kg) IV.
Group II: Etomidate (E) group (0.2 mg/kg) IV.
Randomization was done by opening a sealed envelope just before entry to operating room.
In the operation theater, pulse oximeter, noninvasive blood pressure (BP) apparatus and five lead electrocardiogram (ECG) were connected to the patient.
Swan ganz catheter placement under local infiltration is done as routine in our Institution and to measure preinduction values, i.v. Premedication in our Institution is done after the arrival of patient in OT. After peripheral IV cannulation and intra-arterial radial cannulation, central venous line and pulmonary artery/swan Ganz catheter placement under local infiltration, patient was premedicated with injection glycopyrrolate 0.2 mg IV, injection midazolam 2 mg, injection ranitidine 50 mg and injection ondansetron 4 mg.
After stabilization period of 5 min, the baseline values of heart rate, systolic and diastolic BP (SBP and DBP) (invasive BP), mean arterial pressure (MAP), central venous pressure (CVP), cardiac output (CO), cardiac index (CI), pulmonary capillary wedge pressure (PCWP), SVR, peripheral vascular resistance (PVR), SpO 2 , were recorded and ECG was monitored.
All patients were induced between 8 and 9 am and samples for baseline values of serum cortisol and blood sugar were obtained before induction.
Intravenous fentanyl 2 mcg/kg was given 3 min prior to induction.
After preoxygenation, Group I received 2 mg/kg propofol and Group II received 0.2 mg/kg etomidate for induction.
After the loss of eyelash reflex in both groups, again HR, SBP, DBP, MAP, CVP, PCWP, CO, CI, SVR, PVR were recorded. Injection vecuronium bromide 0.1 mg/kg IV was given, and endotracheal intubation was performed. Again the readings for HR, SBP, DBP, MAP, CVP, PCWP, CO, CI, PVR and SVR were recorded. Intraoperative analgesia was provided with injection fentanyl up to total dose of 20 mcg/kg as intermittent bolus doses. Anesthesia was maintained with isoflurane (0.2-2%) and injection 0.1 mg/kg vecuronium was administered as IV bolus followed by 0.02 mg/kg every 30-40 min. which was significant. Baseline values were comparable in both the groups and no significant changes were observed in etomidate group after induction.
Unlike Group E, Group P showed significant fall in CI after induction which continued till 5 min after intubation as compared to baseline values.
Observations

Hemodynamic parameters
There was no significant difference in between the groups with respect to HR, CVP and PCWP. There was significant decrease in SBP, DBP and MAP between the groups after induction, after intubation and 5 min postintubation. There was significant decrease in CO Heparin in the dose of 300-400 units/kg was administered prior to initiation of CPB during CPB. Serum cortisol values and blood sugar levels were again measured while the patient was on CPB.
Heparin was reversed with protamine in the dose of 4.5 mg/kg after weaning the patient from CPB. Again serum cortisol and blood sugar were measured after heparin reversal.
At the end of surgery, patient was shifted to the cardiac ICU with an endotracheal tube in situ after adequate dose of muscle relaxant and opioid analgesic.
Patients were observed postoperatively for any adverse effects.
HR, IBP, NIBP, CVP, PCWP, CO, CI, SVR, PVR were recorded:
• Baseline/before induction • After the induction (loss of eyelash reflex and verbal response) • Immediately after intubation • After 5 min of intubation.
Endocrine response
Serum cortisol values and blood sugar were measured at 4 time points:
• Baseline before induction of anesthesia • During CPB • After bypass/protamine reversal of heparin after termination of CPB and • At 24 h.
Data were summarized as the number (%) or mean ± standard deviation/median (range) as appropriate. Baseline categorical and continuous variables were compared between the groups using Fisher's exact test and Student's t-test respectively. Hemodynamic variables were compared between the groups using Student's t-test for independent samples. The primary outcome (serum cortisol and blood sugar) of the study was compared between the groups using Wilcoxon Rank Sum test since the data was non-normal. P < 0.05 was considered as significant.
OBSERVATIONS AND RESULTS
There was no significant difference in CO between both the groups though there was significant fall from baseline value in P group after induction [Tables 1 -12] . The values remained below baseline even 5 min after intubation and CI in propofol group when compared to baseline values after induction, after intubation and 5 min after intubation, but not in etomidate group. SVR was significantly decreased after induction in both the groups while the value continued to decrease at 5 min postintubation in the propofol group and increased significantly above baseline in the etomidate group. Values in PVR were significantly decreased after induction in both groups and increased to near baseline levels by 5 min postintubation.
Myoclonus and hypotension
Myoclonus was not seen as the drug was injected slowly. hypotension occured post induction with propofol, it was defined as fall of MAP of more then 10% on the base line. Effects on serum cortisol levels There was significant fall in the cortisol values in etomidate group during bypass and further significant fall after weaning off CPB as compared to the propofol group. The average cortisol value was reduced to approximately 50% at the time of weaning in etomidate group while it increased to almost double in the propofol group.
The serum cortisol level at 24 h was higher as compared to baseline values in both the groups. In the etomidate group, the serum cortisol returned to normal levels which were however almost twice the baseline values. In the propofol group, the serum levels remained high and were about two and a half times the baseline value.
Effects on blood glucose levels There was significant increase in blood glucose value during bypass and when weaning off CPB in both groups compared to baseline and between the two groups, but the rise was less in etomidate group due to decreased stress response because of inhibition of cortisol synthesis. After 24 h of surgery, however the values returned to baseline with no significant differences between the groups.
DISCUSSION
The deleterious effects of anesthetic agents in patients suffering from coronary artery disease are well-known. Induction of general anesthesia may be a critical period during CABG and valve replacement surgery, especially in presence of LV dysfunction. There is a paucity of literature regarding the choice of suitable agent to avoid deleterious effects in such patients. Anesthetic induction techniques for cardiovascular surgery are based on considering hemodynamic stability and effects on myocardial oxygen supply and demand.
Various authors have concern regarding induction of anesthesia with agents such as etomidate, thiopentone, propofol, ketamine and midazolam. However, the use of etomidate and propofol has been considered superior to other IV anesthetic agents in these group of patients. [5] [6] [7] [8] [9] Selection of inducing agent Etomidate (Lipuro. B Braun. Melsungen. Germany) is a short acting IV anesthetic agent used for the induction of general anesthesia. It was introduced as an IV agent in 1972 in Europe and in 1983 in United States. It has a rapid onset of action, a safe cardiovascular risk profile, and lack of histamine release and therefore is less likely to cause a significant drop in BP than other induction agents. It is an ideal induction agent for patients who [3] 1.5
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CONCLUSION
• Etomidate provides more stable hemodynamic parameters when used for induction of anesthesia as compared to propofol in patients with poor LV function • There is a rise in serum Cortisol levels on the initiation of CPB after induction of anesthesia with propofol in our study. This was not present in the etomidate group, where the serum Cortisol levels reduced. Serum Cortisol levels returned to near normal range at 24 h without any untoward effects. The values though were almost twice the baseline" • Etomidate can therefore be safely used as an anesthetic induction agent in patients with poor LV function for CABG/MVR/AVR on CPB without serious cortisol suppression lasting more than 24 h • No untoward incidence was seen with either etomidate or propofol induction.
